Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Diamedica Therapeutics Inc (DMAC)

Diamedica Therapeutics Inc (DMAC)
6.25 x 1 6.28 x 7
Post-market by (Cboe BZX)
6.28 -0.10 (-1.57%) 02/11/25 [NASDAQ]
6.25 x 1 6.28 x 7
Post-market 6.28 unch (unch) 16:00 ET
News & Headlines for Tue, Feb 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Best Momentum Stocks to Buy for October 14th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 14th:IAMGOLD Corporation IAG: This intermediate gold producer has a Zacks Rank #1 and witnessed...

HIVE : 2.72 (-3.89%)
DMAC : 6.28 (-1.57%)
IAG : 6.38 (-1.09%)
New Strong Buy Stocks for October 14th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:HireQuest, Inc. HQI: This company that provides temporary staffing solutions has seen the Zacks Consensus Estimate for its current...

HIVE : 2.72 (-3.89%)
HQI : 12.82 (-1.00%)
CLPR : 3.96 (+0.25%)
DMAC : 6.28 (-1.57%)
IAG : 6.38 (-1.09%)
Three (3) Stocks Under $10 That Insiders Are Buying 

These small-cap names provide an opportunity that insiders are buying including deep value, growth, new technology, and AI.

DMAC : 6.28 (-1.57%)
ADT : 7.48 (+1.36%)
CMTL : 2.20 (-3.93%)
DiaMedica Therapeutics to Report First Quarter 2023 Financial Results and Provide a Business Update May 16, 2023

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company currently focused on developing recombinant KLK1 (DM199) for the treatment of acute ischemic stroke, announced today...

DMAC : 6.28 (-1.57%)
DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing a novel treatment for acute ischemic stroke (AIS), today announced the appointment of David...

DMAC : 6.28 (-1.57%)
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2022 Financial Results

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update...

DMAC : 6.28 (-1.57%)
DiaMedica Therapeutics to Report Fourth Quarter 2023 Financial Results and Provide a Business Update March 29, 2023

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company currently focused on developing recombinant KLK1 (DM199) for the treatment of acute ischemic stroke, announced today...

DMAC : 6.28 (-1.57%)
DiaMedica Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that Rick Pauls,...

DMAC : 6.28 (-1.57%)
DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointment...

DMAC : 6.28 (-1.57%)
KPTI : 0.5981 (-3.98%)
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update...

DMAC : 6.28 (-1.57%)

Barchart Exclusives

Is Cotton Cheap at Below 70 Cents per Pound?
Cotton futures reached an eleven-year high of over $1.50 per pound in 2022 but ran out of upside steam. They last traded above $1 in March 2024 before falling under the 70 cents per pound level. As the cotton market heads into the 2025 crop year, the price is at an attractive level that could have significant upside potential. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Optimizing Trade Entries with the Futures Trading Guide